CS Paper Radar

Evidence-Anchored Overdose Death Prediction from Death Investigation Reports

Raavi Gupta, Ziqing Yang, Karli R. Hochstatter, Talia Nadel, Nicole D'Anna, Jason K. Graham, Hannah Johnson, Kelsey Opozda, Nabila El-Bassel, Anubhav Jangra, Smaranda Muresan

cs.CL cs.AIcs.LG ·submitted 2026-10-14 04:13 UTC · v1

Abstract

Confirmation of overdose deaths in the United States is often delayed due to the complexities of certifying drug-involved deaths. Death investigation reports represent a rich but underutilized data source that could be used to predict whether a death is a suspected overdose (i.e., a death preliminarily identified as an overdose prior to the final cause and manner of death determination). We present an automated framework that classifies suspected overdoses from death investigation reports, while producing supporting explanations guided by expert knowledge. Through an expert-guided design process, we investigate 1) what type of explanations are best for model prediction performance, and 2) which architecture is better suited for this task: pipeline models that rationalize first and then predict, or self-rationalizing models that jointly predict and rationalize? Our experiments show that a pipeline model with explanations grounded in the input death investigation reports outperforms the other settings. Our best model also outperforms a rule-based system currently in deployment by 15%, while allowing expert interventions for final decisions.

Closest papers

Nearest neighbours by meaning across the whole index.

OverdoseMoE: A Multi-Expert Framework for Opioid Overdose Risk Prediction

cs.CL ·2026-09-30 ·Mingchen Li, Rohan Pandey, Junhui Qian, Feiyun Ouyang, Sunjae Kwon +1 more
similarity 0.69
Abstract

Opioid overdose remains a major clinical and public health burden, highlighting the need for scalable approaches to identify patients at high risk. Here, we investigate diagnosis-specific adaptation for 180-day opioid overdose risk prediction from patients' preceding one-year longitudinal ICD histories. We develop OODMAMBA and OODQWEN through continued pretraining on longitudinal diagnostic sequences followed by task-specific fine-tuning. Building on the stronger Qwen-based predictors, we further propose OVERDOSEMOE, a multi-expert framework that integrates models of different scales using complementary expert-weighting strategies. Diagnosis-specific adaptation consistently improved predictive performance over general-purpose language-model baselines, with OODQWEN achieving an AUPRC of 24.47 and an AUROC of 68.56. OVERDOSEMOE further improved discrimination and precision, achieving an AUPRC of 25.17 and an AUROC of 69.49 while outperforming the strongest single-model baselines. Among patients ranked in the top 5% of predicted risk, OVERDOSEMOE identified substantially enriched overdose risk, achieving a PPV of 25.38% while retaining meaningful recall. Evaluation on an independent MIMIC-IV cohort further demonstrated cross-cohort robustness, with complementary weighting strategies showing advantages across different performance measures. These findings demonstrate that diagnosis-specific language-model adaptation combined with multi-expert integration can improve opioid overdose risk stratification and support more robust prediction across heterogeneous electronic health record populations.

0.18

CARF: Context-Aware Reasoning Supervision for Scientific Evidence Screening

cs.CL ·2026-10-27 ·Nishtha Agarwal, Adam Visokay, Astha Wahi, Kwabena Owusu Aninkora, Amy Gu +2 more
similarity 0.65
Abstract

Systematic reviews synthesize biomedical evidence to inform clinical and public-health decision-making, but require domain experts to manually screen thousands of studies against detailed eligibility criteria. We investigate whether language models can assist with this bottleneck by learning from expert feedback on title and abstract screening decisions and model-generated reasoning. We introduce the Context-Aware Reasoning Framework (CARF), a human-in-the-loop framework that uses expert feedback on model-generated reasoning to adapt language models to context-dependent screening tasks. We evaluate CARF on systematic reviews of verbal autopsy and cause-of-death ascertainment methods used in global public health mortality surveillance. CARF shows competitive screening performance compared to evaluated models while retaining high sensitivity, and is more inclined to retain ambiguous, context-dependent studies for human review. Together, these findings suggest that expert-corrected reasoning is a promising supervision signal for context-dependent scientific screening, while retaining a role for human oversight.

0.18

Analysis of Prompt Engineering for Drug Toxicity Prediction

cs.AI ·2026-09-03 ·Mia MacGregor, Aakash Welgamage Don, Mark Bartlett
published similarity 0.63
Abstract · Accepted at the CIBB 2026 conference (https://cibb2026.teralab.ai/)

Clinical trials in the UK can cost up to £1.3 million, with approximately 90% drug failure rate. Toxicity is a major contributing factor in drug failure. Testing is time and cost intensive. In recent years, the use of artificial intelligence has been increasingly explored to aid in the prediction of drug toxicity, with extensive use of large language models (LLMs). However, LLMs can show considerable variation when minor changes are made to prompts, which raises concerns about their sensitivity to prompt engineering. Prompt engineering is used to optimise a prompt given to an LLM to generate the desired output. This paper proposes a method to analyse prompt engineering for drug toxicity prediction. The aim of the paper is to investigate the importance of prompt phrasing for drug toxicity prediction. LLMs were prompted to identify chemical properties of significance when predicting drug toxicity. Prompts were constructed to investigate; job role, prompt structuring, and rule interpretation. LLMs were then used to generate datasets, using the identified features from initial prompting, which were then passed to machine learning algorithms. The experiments show that the natural variance which occurs in LLMs outweighs any fine-tuning of prompts. There were, however, substantial improvements in model performance when using chemoinformatic code to extract features instead of using LLM-generated values. The proposed analysis methodology is applicable to a wide range of prompt types across different areas of bioinformatics.

0.39

RAG-Enhanced LLMs for Interactive Explainability in Clinical Decision Support Systems

cs.AI cs.HCcs.LG ·2026-11-06 ·Lorenzo Mannocci, Francesca Naretto, Lucia Passaro, Anna Monreale
published similarity 0.60
Abstract · Published in HC_AIxIA_HYDRA 2025, Communications in Computer and Information Science, vol. 2830, pp. 50-63, Springer, 2026. Please cite the …

Artificial Intelligence (AI) is increasingly embedded in high-risks decision-making systems across domains such as healthcare, finance, and the judicial system. As reliance on predictive models grows, so does the demand for Explainable AI (XAI) to ensure transparency, trust, and interpretability. However, existing XAI approaches often fail to present explanations in a format accessible to domain experts, limiting their practical utility. Large Language Models (LLMs) have recently emerged as a bridge between complex models and end-users, offering natural language explanations. Yet, their use introduces new risks, including hallucinated outputs and lack of source traceability. To address these challenges, we propose a Clinical Decision Support System (CDSS) that not only combines standard predictive models with XAI techniques but also incorporates a Retrieval-Augmented Generation module as an interactive enhancer. This module grounds explanations in verified medical knowledge, reformulates technical outputs into a human-like format, and enables users-such as clinicians-to actively query the system. By fostering an interactive, human-in-the-loop environment, our approach empowers domain experts to explore model decisions, contextualize explanations, and build trust in AI-assisted diagnostics. The study concludes with preliminary experiments validating the proposed methodology.

0.20

Cite What You Explore: Budget-Aware LLM Reasoning over Medical KGs with Verifiable Evidence

cs.LG ·2026-10-06 ·Chen Chen, Dongjie Wang, Mei Liu, Zijun Yao
top venuebenchmarkcode/data similarity 0.59
Abstract · Accepted to NeurIPS 2026. This revision corrects cohort statistics and efficiency reporting, removes incorrectly reported per-disease standa…

Post-discharge risk prediction from electronic health records (EHRs) is difficult because many dependencies that link discharge-time observations to downstream complications, such as comorbidity cascades and drug-disease interactions, are absent from the record. External medical knowledge graphs (KGs) can supply these missing dependencies, but tracing them in a clinical setting demands three properties. KG exploration must remain cost-bounded, retrieved evidence must be differentiated by source quality, and the resulting rationale must be citable for review. Large language models (LLMs) can plan and verify over structured evidence, making them natural candidates for KG reasoning, but existing LLM-based methods do not satisfy these three properties jointly. In this paper, we propose BAR, a Budget-Aware LLM Reasoning framework over medical KGs with three contributions. First, BAR refines the raw KG into disease-specific evidence graphs whose edges carry support scores and provenance records, turning the KG into a quality-annotated reasoning space rather than a static feature source. Second, an LLM reasons over this graph through a plan-navigate-verify loop that decomposes the question into steps, retrieves evidence under a patient-specific budget, and revises when verification fails. Third, a reasoning policy is trained with a reward that compares predictions with and without acquired evidence, combined with acquisition cost and citation-integrity terms. Across 8 diseases and 3 prediction horizons on MIMIC-III and MIMIC-IV, BAR achieves higher performance and citation precision than strong baselines while using fewer LLM tokens. Its gain over EHR-only prediction grows at longer horizons, and its advantage carries over to an external benchmark.

0.36

Learning Under Treatment-Induced Label Indeterminacy with Expert Annotations of Counterfactual Outcomes: A Case Study in Neurological Prognostication

cs.LG ·2026-08-12 ·Xiaobin Shen, Chloe Y. H. Huang, Jonathan Elmer, George H. Chen
similarity 0.59
Abstract · Machine Learning for Healthcare (MLHC) 2026

Clinical prediction models are often developed as if the outcome of interest were cleanly observed for every patient. This assumption fails when treatment decisions make the clinically relevant outcome permanently unobservable. As a case study of this problem, we consider post-cardiac-arrest neurological prognostication using a cohort of 2,497 patients, including 1,429 patients whose outcomes were rendered indeterminate by treatment decisions. These patients with indeterminate outcomes were reviewed by independent clinical experts, who provided their guesses of counterfactual outcomes about what would have happened to the patients. We refer to these patients as uncertain cases. We also have patients for whom we observe their clinically relevant outcomes; we refer to these patients as certain cases. We propose a framework for evaluating prediction models that explicitly splits the evaluation between certain and uncertain cases. Here, we cannot easily evaluate both types of cases in a uniform manner as the available target labels differ. We then propose a simple prediction model that uses target labels from both certain and uncertain cases in a manner that allows us to trade off between them. Across the proposed neural model and a collection of tabular baselines, models with similar certain-case AUROC can nevertheless differ substantially in both certain-case Brier score and their probability estimates for uncertain cases. Improving alignment with target labels of uncertain cases for our proposed model generally comes at the cost of worse accuracy on certain cases, highlighting an explicit tradeoff that standard evaluation conceals. These results show that when treatment decisions determine whether clinically meaningful outcomes remain observable, conventional evaluation metrics can miss important failure modes in the very patients for whom prognostic support matters most.

0.04

AI Morbidity and Mortality: A Framework for Clinical AI Failure Review

cs.AI cs.HC ·2026-08-31 ·Paulius Mui, Dean F. Sittig, Steve Labkoff, Sanjay Basu
similarity 0.58
Abstract

Clinical artificial intelligence is increasingly embedded in real-world care, yet existing safety mechanisms are poorly suited to reconstructing and learning from individual AI-related errors and near-misses. Aggregate model monitoring can identify performance changes, and traditional patient safety reporting can capture adverse events, but neither is designed to explain how risk emerges across the interaction among AI systems, clinicians, workflows, and institutional controls. We propose AI Morbidity and Mortality (AI M&M), a structured, blameless framework for case-based review of clinical AI failures. The framework combines standardized case intake, evidence preservation and investigator-level reconstruction, tool-in-loop attribution, and corrective-action tracking. Each event is classified across four linked dimensions: Trigger - Mechanism - Clinical Pathway - Corrective Action, separating the condition that exposed a vulnerability from the process that produced risk, its consequence for care, and the remediation assigned. We demonstrate the framework using five illustrative outpatient medication and clinical decision-support cases; two clinician reviewers independently applied all four classification axes and reached agreement across all 20 axis-level classifications. AI M&M is intended to complement, rather than replace, model monitoring, patient safety reporting, and regulatory oversight by converting individual AI-in-workflow failures into actionable institutional learning. Prospective evaluation across institutions, AI systems, and clinical settings is needed.

0.13

DynSurvX: Time-Resolved Explanations for Dynamic Survival Predictions

cs.LG ·2026-11-16 ·Van Tuan Nguyen, Agathe Guilloux
top venue similarity 0.58
Abstract

Recent survival models integrating longitudinal data achieve strong predictive performance, but their predictions are often difficult to interpret, limiting their clinical use. We propose DynSurvX, a model-agnostic explainability framework for dynamic survival prediction with mixed static and longitudinal covariates. Based on Shapley values, DynSurvX introduces a hierarchical two-phase strategy that first identifies influential longitudinal features and then adaptively refines their temporal importance, enabling fine-grained explanations while reducing computational cost. The framework provides time-resolved explanations that evolve as new patient data become available. Experiments on simulated and two clinical datasets show varying agreement with theoretical importance across prediction models, with closer agreement for better-performing models, alongside clinically interpretable insights in real-world settings. It remains robust across prediction settings and reduces computation time by 41--80\% relative to the temporal explanation baseline, making dynamic explanations practical.

0.28